32+ min ago  (1573+ words) 09 Jul 2026, 23: 50 In many ways, the human body is an undiscovered country." But this lack of knowledge, in turn, represents an opportunity " one that firms such as Recursion are hoping to unlock with artificial intelligence (AI). This represents a new model…...

1+ hour, 2+ min ago  (524+ words) The platform pairs specially engineered adeno-associated viruses (AAVs) with a delivery strategy that harnesses the brain's natural fluid transport pathways. Together, these innovations enabled researchers to deliver therapeutic genes broadly throughout the brain, preferentially targeting human glial cells while minimizing…...

1+ hour, 10+ min ago  (141+ words) July 9, 2026 Amy Easton Target ALS is excited to award new grants totaling $2. 75 M to 6 consortia to evaluate the basic biology and underlying disease mechanisms of ALS. This set of proposals is notable for their incorporation of innovative methods including AI…...

2+ hour, 24+ min ago  (696+ words) By Drug Target Review July 09, 2026 A USC-led team has combined single-cell developmental mapping with synthetic biology to produce kidney organoids that more faithfully recapitulate human embryonic kidney formation. Scientists at the University of Southern California (USC) have developed a new…...

3+ hour, 19+ min ago  (1641+ words) July 9, 2026 | Thursday | News Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-Hydroxy-1, 4-Naphthalenedione for use in the treatment of cancer." This patent covers a novel class of compounds that have demonstrated strong…...

4+ hour, 22+ min ago  (311+ words) The Indian Practitioner Godavari Biorefineries Limited bagged a patent from the Japan Patent Office for its breakthrough invention, "5-Hydroxy-1, 4-Naphthalenedione for Use in the Treatment of Cancer." The patent strengthens the company's global intellectual property portfolio and reinforces its growing…...

5+ hour, 17+ min ago  (263+ words) The partnership will connect Evogene's AI-based Chem Pass AI with the BCDD's laboratory infrastructure. Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery (BCDD) have announced a collaboration that aims to expedite the development of small-molecule drug discovery originating…...

5+ hour, 44+ min ago  (87+ words) Machine learning and robotics could accelerate a two-year probiotic development process to four to five months, with a recent presentation at the IPA World Congress + Probiota highlighting the potential of this disruptive technology for strain optimization. Possibly the two biggest…...

6+ hour, 52+ min ago  (300+ words) Businesskorea Samsung Bioepis Co. , Ltd. announced today that it has entered into a license agreement with Proteina Co. , Ltd. to collaborate on a government-supported national R&D initiative aimed at developing AI-based antibody therapeutics. The R&D initiative titled "Development…...

12+ hour, 23+ min ago  (118+ words) Taking place at Bio Process International Theater at BIO June 2026, Kevin Zen, Senior Director, CMC Technical Operations, Opthea, discusses innovations and trends in biologics development through analytical technologies. Jun 7, 2027 TO Jun 10, 2027 The BIO International Convention is Biotechnology Innovation Organization (BIO)…...